Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Par Pharmaceutical Companies Inc.

http://www.parpharm.com

Latest From Par Pharmaceutical Companies Inc.

Finance Watch: Founder-Friendly Curie.Bio Launches With $520m To Seed, Support New Companies

Private Company Edition: Alexis Borisy and his Curie.Bio co-founders will invest $5m-$7m to help companies get to lead optimization within 12-18 months. Also, Feng Zhang-founded Aera launched with $193m, Hexagon Bio raised a $77.3m series B round and Halda emerged with $76m.

Financing Innovation

FTC Objections To Pharma Mergers Could Go Unchallenged Following Wilson’s Resignation

The commission no longer has a voice opposing aggressive antitrust enforcement actions and President Biden's replacement may be more receptive to the stance of the three current Democratic commissioners. Amgen’s proposed acquisition of Horizon is facing FTC scrutiny.

Enforcement Legal Issues

China's Ongoing 'COVID Zero' Policies To Prompt More Domestic Deals?

China biotechs appear increasingly interested in partnering with domestic counterparts amid signs the Chinese government's restrictive "COVID Zero" policies are likely to stay until well into 2023.

China Coronavirus COVID-19

FTC’s Take On Two Pharma Mergers Shows Deals Can Clear Higher Hurdle

Pfizer’s acquisition of Arena without FTC intervention and Hikma’s acquisition of Custopharm with one product divestiture shows the commission is bound by anticompetitive facts of a deal. A more controversial merger may not get through, former FTC attorney says.

M & A Commercial
See All

Company Information

  • Other Names / Subsidiaries
    • Anchen Pharmaceuticals, Inc.
    • Edict Pharmaceuticals Private Limited
    • JHP Pharmaceuticals, LLC
    • Strativa Pharmaceuticals
    • TPG Capital LP
UsernamePublicRestriction

Register